Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT
Clinical trial NCT06963866 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06963866
- Sponsor
- Xuzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2028-04-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.